Immunogenicity & Safety of Bio Farma’s Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study)
Condition(s):Congenital Rubella Infection; MeaslesLast Updated:December 4, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Congenital Rubella Infection; MeaslesLast Updated:December 4, 2019Completed
Condition(s):Vaccine Reaction; Vaccine Adverse ReactionLast Updated:September 19, 2022Not yet recruiting
Condition(s):VaccineLast Updated:September 19, 2022Active, not recruiting
Condition(s):Cesarean Section; Hypotension Drug-Induced; Spinal Anesthesia; Postoperative ComplicationsLast Updated:February 11, 2019Completed
Condition(s):Safety Issues; ImmunogenicityLast Updated:February 20, 2020Completed
Condition(s):Body ImageLast Updated:July 25, 2023Completed
Condition(s):Nutritional Anemia; Child DevelopmentLast Updated:March 5, 2014Unknown status
Condition(s):Drug UseLast Updated:March 3, 2023Completed
Condition(s):ThalassemiaLast Updated:May 11, 2021Unknown status
Condition(s):Cognitive Impairment; Dementia; Hearing Impairment; Vision Impairment and Blindness; Diabetes; Dyslipidemias; Obesity; Central Obesity; Mobility Limitation; Osteoarthritis; Hypertension; DepressionLast Updated:September 13, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.